Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 1.59% for the current model date.
BlackTreeCVE IntelligenceOracle Corporation · FLEXCUBE Enterprise Limits and Collateral Management
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Patch availableVulnerability in the Oracle FLEXCUBE Enterprise Limits and Collateral Management component of Oracle Financial Services Applications (subcomponent: Infrastructure). Supported versions that are affected are 12.3.0, 14.0.0 and 14.1.0. Difficult to exploit vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle FLEXCUBE Enterprise Limits and Collateral Management. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle FLEXCUBE Enterprise Limits and Collateral Management accessible data. CVSS 3.0 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N).
Vulnerability in the Oracle FLEXCUBE Enterprise Limits and Collateral Management component of Oracle Financial Services Applications (subcomponent: Infrastructure). Supported versions that are affected are 12.3.0, 14.0.0 and 14.1.0. Difficult to exploit vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle FLEXCUBE Enterprise Limits and Collateral Management. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle FLEXCUBE Enterprise Limits and Collateral Management accessible data. CVSS 3.0 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N).
The current structured CVE record identifies a security weakness, but the root cause requires confirmation in the linked vendor material.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
Vulnerability in the Oracle FLEXCUBE Enterprise Limits and Collateral Management component of Oracle Financial Services Applications (subcomponent: Infrastructure). Supported versions that are affected are 12.3.0, 14.0.0 and 14.1.0. Difficult to exploit vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle FLEXCUBE Enterprise Limits and Collateral Management. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle FLEXCUBE Enterprise Limits and Collateral Management accessible data. CVSS 3.0 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N).
The current structured CVE record identifies a security weakness, but the root cause requires confirmation in the linked vendor material.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:NCommon Vulnerability Scoring System 3.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 18 Jul 2018 · Last source change 2 Oct 2024, 20:02 UTC · CWE not yet assigned
Missing structured fields: CWE classification. Missing data is not evidence of low risk; review the primary advisory.